John B. Pedersen
Amministratore Delegato presso Augmenix, Inc.
Profilo
John B.
Pedersen is currently the President, Chief Executive Officer & Director at Augmenix, Inc., Chairman at DYSIS Medical Ltd., and a Member of Young Presidents' Organization (New England).
Previously, he was the SVP, President-Urology & Womens Health at Boston Scientific Corp.
from 2010 to 2012 and a Senior Engagement Manager at McKinsey & Co., Inc. He received his undergraduate degree from Princeton University and his MBA from Harvard Business School.
Posizioni attive di John B. Pedersen
Società | Posizione | Inizio |
---|---|---|
Young Presidents' Organization (New England) | Corporate Officer/Principal | 02/04/2010 |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA. | Amministratore Delegato | 13/01/2015 |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Presidente | 01/12/2019 |
Precedenti posizioni note di John B. Pedersen
Società | Posizione | Fine |
---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
BOSTON SCIENTIFIC CORPORATION | Direttore/Membro del Consiglio | 06/03/2012 |
Formazione di John B. Pedersen
Princeton University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Aziende private | 4 |
---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Young Presidents' Organization (New England) | |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA. | Health Technology |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- John B. Pedersen